A study of talimogene laherparepvec in pediatric subjects with tumors that are able to be directly injected and do not occur in the spinal cord or brain

Update Il y a 4 ans
Reference: EUCTR2015-003645-25

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the safety and tolerability of talimogene laherparepvec, as assessed by incidence of dose-limiting toxicities (DLT), in pediatric subjects with advanced non central nervous system (CNS) tumors that are amenable to direct injection.


Inclusion criteria

  • Non-Central Nervous System (CNS) Tumors

Links